logoTry Persana

insitro - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about insitro including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

insitro company logo

Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale.

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

HeadquartersSouth San Francisco, United States
Team size201-500
Founded2018

What is insitro? - Company Overview & Details

insitro is insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. Founded in 2018, the company is headquartered in South San Francisco, United States.

Who Founded insitro?

insitro was founded by Daphne Koller.

Who are the Key Executives at insitro? - Leadership Team

insitro is led by experienced executives in key positions:

insitro Company Details & Key Information

Where is insitro located?

insitro is headquartered in South San Francisco, United States.

How many employees does insitro have?

insitro has 201-500 employees.

When was insitro founded?

insitro was founded in 2018.

How much funding has insitro raised?

insitro has raised $1.4 Billion across 3 funding rounds. The most recent funding was completed on 2021-04-15.

Funding Overview

Insitro has raised a total of $1.4 billion from various funding rounds, including significant investments for its innovative machine learning-driven drug discovery platform.

$1.4 Billion
Total Funding Raised
3
Funding Rounds
2021-04-15
Latest Round

insitro Funding History

Series C
2021-04-15
$400 Million
Series B
2020-06-01
$143 Million
Series A
2019-01-01
$100 Million

Who are the key investors in insitro?

insitro is backed by 4 key investors including Canada Pension Plan Investment Board, SoftBank Group, Andreessen Horowitz. These investors focus on Healthcare, Biotechnology, Technology sectors.

insitro Investor Overview

4
Key Investors
3
Focus Areas
4
Notable Investments

Complete List of insitro Investors

Canada Pension Plan Investment Board

A Canadian institutional investor that manages funds for the Canada Pension Plan, focusing on the best return on investment.

Investment Focus
Healthcare
Biotechnology
Notable Portfolio Companies
Insitro

SoftBank Group

A multinational conglomerate holding company focused on technology and innovation investments.

Investment Focus
Technology
Biotechnology
Notable Portfolio Companies
Insitro

Andreessen Horowitz

A private venture capital firm that specializes in investing in technology companies.

Investment Focus
Technology
Healthcare
Notable Portfolio Companies
Insitro

Arch Venture Partners

A venture capital firm specializing in early-stage biotechnology companies.

Investment Focus
Biotechnology
Healthcare
Notable Portfolio Companies
Insitro

What sectors do insitro investors focus on?

The investors backing insitro primarily focus on Healthcare, Biotechnology, Technology sectors.

Healthcare
Biotechnology
Technology

Featured Investor: Canada Pension Plan Investment Board

Canada Pension Plan Investment Board

A Canadian institutional investor that manages funds for the Canada Pension Plan, focusing on the best return on investment.

Notable Investments: Insitro

What are insitro's future plans?

insitro insitro aims to advance its lead programs toward clinical development, particularly in neuroscience and oncology.

insitro Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does insitro face?

insitro has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for insitro

1

Identifying and validating new therapeutic targets

2

Navigating regulatory approval processes

What opportunities does insitro have?

insitro has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for insitro

1

Expanding partnerships with pharmaceutical companies

2

Leveraging AI for new drug discovery

insitro Strategic Position Summary

Key Focus Areas

insitro is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about insitro?

insitro has 2 recent news updates covering key business developments and market activities.

insitro News Overview

2
Recent Articles
Active
Media Coverage
2024-12-18
Latest Update

What is insitro in the news for?

insitro is currently featured in news for Insitro, Inc. receives financing of $25M. and other significant business developments.

Recent News Articles About insitro

Article 1
2024-12-18

Insitro, Inc. receives financing of $25M.

Insitro receives $25 million in milestone payments from Bristol Myers Squibb for discovery achievements related to ALS.

stocktitan.net
Read News
Article 2
2024-07-01

Insitro, Inc. invests into Xaira Therapeutics, Inc. $600M.

Insitro raised over $600 million through investments, reinforcing its position among AI biotechs.

sdbj.com
Read News

insitro FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about insitro including information about founders, CEO, funding history, investors, headquarters location, and company details. 15 frequently asked questions covering key information about the company.

insitro Questions & Answers - Company Information

Q1

What is insitro?

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

Q2

Who founded insitro?

insitro was founded by Daphne Koller.

Q3

How much funding has insitro raised?

insitro has raised a total of $$1.4 Billion across 3 funding rounds. The most recent funding was completed on 2021-04-15.

Q4

Who are the investors in insitro?

insitro's key investors include Canada Pension Plan Investment Board, SoftBank Group, Andreessen Horowitz, Arch Venture Partners.

Q5

Where is insitro headquartered?

insitro is headquartered in South San Francisco, United States.

Q6

When was insitro founded?

insitro was founded in 2018.

Q7

How many employees does insitro have?

insitro has 201-500 employees.

Q8

What was insitro's latest funding round?

insitro's latest funding round was a Series C round of $$400 Million completed on 2021-04-15.

Q9

What does the company do?

insitro is a machine learning-powered drug discovery and development company focused on transforming medicine development.

Q10

How much funding?

$1.4 Billion

Q11

Latest funding date?

2021-04-15

Q12

Who are the investors?

Canada Pension Plan Investment Board SoftBank Group Andreessen Horowitz Arch Venture Partners

Q13

What are the challenges?

Identifying and validating new therapeutic targets Navigating regulatory approval processes

Q14

What are the opportunities?

Expanding partnerships with pharmaceutical companies Leveraging AI for new drug discovery

Q15

Latest news?

Insitro receives $25 million in milestone payments from Bristol Myers Squibb for discovery achievements related to ALS. Insitro raised over $600 million through investments, reinforcing its position among AI biotechs.

More Information About insitro

For additional details about insitro, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.